College of Health Sciences, Makerere University, Kampala, Uganda.
National Malaria Control Division, Kampala, Uganda.
Malar J. 2020 Aug 26;19(1):300. doi: 10.1186/s12936-020-03362-x.
Histidine-rich protein-2 (HRP2)-based rapid diagnostic tests (RDTs) are the only RDTs recommended for malaria diagnosis in Uganda. However, the emergence of Plasmodium falciparum histidine rich protein 2 and 3 (pfhrp2 and pfhrp3) gene deletions threatens their usefulness as malaria diagnostic and surveillance tools. The pfhrp2 and pfhrp3 gene deletions surveillance was conducted in P. falciparum parasite populations in Uganda.
Three-hundred (n = 300) P. falciparum isolates collected from cross-sectional malaria surveys in symptomatic individuals in 48 districts of eastern and western Uganda were analysed for the presence of pfhrp2 and pfhrp3 genes. Presence of parasite DNA was confirmed by PCR amplification of the 18s rRNA gene, msp1 and msp2 single copy genes. Presence or absence of deletions was confirmed by amplification of exon1 and exon2 of pfhrp2 and pfhrp3 using gene specific PCR.
Overall, pfhrp2 and pfhrp3 gene deletions were detected in 29/300 (9.7%, 95% CI 6.6-13.6%) parasite isolates. The pfhrp2 gene was deleted in 10/300 (3.3%, 95% CI 1.6-6.0%) isolates, pfhrp3 in 9/300 (3.0%, 95% CI 1.4-5.6%) while both pfhrp2 and pfhrp3 were deleted in 10/300 (3.3%, 95% CI 1.6-6.0%) parasite isolates. Proportion of pfhrp2/3 deletions was higher in the eastern 14.7% (95% CI 9.7-20.0%) compared to the western region 3.1% (95% CI 0.8-7.7%), p = 0.001. Geographical location was associated with gene deletions aOR 6.25 (2.02-23.55), p = 0.003.
This is the first large-scale survey reporting the presence of pfhrp2/3 gene deletions in P. falciparum isolates in Uganda. Roll out of RDTs for malaria diagnosis should take into consideration the existence of pfhrp2/3 gene deletions particularly in areas where they were detected. Periodic pfhrp2/3 surveys are recommended to inform future decisions for deployment of alternative RDTs.
组氨酸丰富蛋白 2(HRP2)-基于快速诊断测试(RDT)是乌干达唯一推荐用于疟疾诊断的 RDT。然而,恶性疟原虫 HRP2 和 3(pfhrp2 和 pfhrp3)基因缺失的出现威胁到它们作为疟疾诊断和监测工具的有用性。在乌干达对恶性疟原虫寄生虫种群进行了 pfhrp2 和 pfhrp3 基因缺失监测。
从乌干达东部和西部 48 个地区的有症状个体的横断面疟疾调查中收集了 300 株(n=300)恶性疟原虫分离株,分析了 pfhrp2 和 pfhrp3 基因的存在情况。通过聚合酶链反应(PCR)扩增 18s rRNA 基因、msp1 和 msp2 单拷贝基因来确认寄生虫 DNA 的存在。使用基因特异性 PCR 扩增 pfhrp2 和 pfhrp3 的外显子 1 和外显子 2,以确认缺失的存在或不存在。
总体而言,在 300 个寄生虫分离株中,有 29 个(9.7%,95%CI 6.6-13.6%)检测到 pfhrp2 和 pfhrp3 基因缺失。10 个(3.3%,95%CI 1.6-6.0%)分离株缺失 pfhrp2 基因,9 个(3.0%,95%CI 1.4-5.6%)分离株缺失 pfhrp3 基因,10 个(3.3%,95%CI 1.6-6.0%)分离株同时缺失 pfhrp2 和 pfhrp3 基因。东部地区 pfhrp2/3 缺失的比例较高,为 14.7%(95%CI 9.7-20.0%),而西部地区为 3.1%(95%CI 0.8-7.7%),p=0.001。地理位置与基因缺失相关,比值比(aOR)为 6.25(2.02-23.55),p=0.003。
这是首次在乌干达大规模报告恶性疟原虫分离株中存在 pfhrp2/3 基因缺失的研究。在推出用于疟疾诊断的 RDT 时,应考虑到 pfhrp2/3 基因缺失的存在,特别是在检测到这些缺失的地区。建议定期进行 pfhrp2/3 调查,以便为未来部署替代 RDT 做出决策提供信息。